Jiz Alphons Jordan, PA
Medical · Sugar Land, TXNPI 1487103396
Payments from drug & device makers
Across 54 payments — averaging $19.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$126
- Corium, LLC$71
- GSK$70
- Cranial Technologies, Inc$65
- AstraZeneca$62
- Lilly USA, LLC$57
- plus $590 from 21 others
What the payments were for
- Food & beverage$1,042100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 6 | $126 |
| Corium, LLC | 3 | $71 |
| GSK | 4 | $70 |
| Cranial Technologies, Inc | 4 | $65 |
| AstraZeneca | 3 | $62 |
| Lilly USA, LLC | 3 | $57 |
| Pfizer | 2 | $47 |
| Ironshore Pharmaceuticals Inc. | 3 | $47 |
| Abbott | 2 | $47 |
| Hologic Sales And Service, LLC | 2 | $45 |
| Sanofi Pasteur Inc. | 2 | $43 |
| Exact Sciences | 2 | $41 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $34 |
| Alvogen Inc | 1 | $29 |
| Bayer | 1 | $20 |
| Antares Pharma, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| AbbVie | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Merck | 1 | $15 |
| Tolmar, Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| VBI Vaccine (delaware) Inc. | 1 | $12 |
How this compares
$1,042 in reported general payments places this provider in the 55th percentile of 1,490 medical providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 82 | $919 |
| Azelastine Hcl | 15 | $751 |
| Levothyroxine Sodium | 36 | $295 |
| Montelukast Sodium | 22 | $288 |
| Metoprolol Tartrate | 18 | $266 |
| Fluticasone Propionate | 18 | $223 |
| Sertraline Hcl | 16 | $205 |
| Lisinopril | 30 | $202 |
| Amlodipine Besylate | 23 | $188 |
| Rosuvastatin Calcium | 12 | $173 |
| Metoprolol Succinate | 11 | $159 |
| Escitalopram Oxalate | 12 | $149 |
| Glipizide ErGlipizide | 15 | $145 |
| Allopurinol | 13 | $143 |
| Omeprazole | 13 | $130 |
Paid to pharmacies, not to this prescriber.
Other medical in Sugar Land
- Jennifer HendersonSugar Land$19K
- Deanna WallaceSugar Land$17K
- Jose de la CerdaSan Antonio$1.1M
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Courtney AldridgeSan Antonio$129K
- Shakira CabreraSan Antonio$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.